Plasmid– tag –
-
AGC Biologics Highlights Strengths as Global CDMO Partner for Biologics and Advanced Therapies
The Economy Global Overview AGC Biologics is recognized as a global biopharmaceutical CDMO providing development and manufacturing services across a wide range of advanced modalities, including biologics, plasmid DNA, mRNA, viral vectors... -
ProBio Establishes Cell and Gene Therapy CDMO Center of Excellence in Hopewell, New Jersey, Specializing in Plasmid DNA and Viral Vector Manufacturing
ProBio USA Overview ProBio has opened a Cell and Gene Therapy Center of Excellence in Hopewell, New Jersey, focusing on the development and GMP manufacturing of plasmid DNA and viral vectors. This new facility is designed to meet stringe... -
4basebio and Genezen Partner to Revolutionize Viral Vector Manufacturing: hpDNA Boosts AAV Titers by up to 33-fold
AllSci Overview 4basebio and Genezen have announced a strategic collaboration to integrate 4basebio's hpDNA platform into viral vector manufacturing workflows, aiming to significantly enhance efficiency. This innovative cell-free synthet... -
4basebio and Genezen Partnership Revolutionizes Viral Vector Manufacturing: Cell-Free Synthetic DNA Reduces Costs by 30%
BioPharm International USA Overview 4basebio and viral vector CDMO Genezen announced a partnership to integrate 4basebio's cell-free hpDNA platform into Genezen's manufacturing workflow. This innovative technology enzymatically produces ... -
PackGene Biotech’s π-alpha 293 Platform Achieves 10x AAV Production Amplification, Up to 1e+17vg/Batch, Supporting Remedium Bio’s Gene Therapy Advancement
PackGene Biotech China Overview PackGene Biotech announced its innovative π-alpha 293 AAV high-yield platform, capable of amplifying adeno-associated virus (AAV) production up to 10-fold and achieving an impressive yield of up to 1e+17vg... -
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
ProBio Opens $25 Million Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, Creating Over 100 Highly Skilled Jobs
New Jersey Business Magazine USA Overview ProBio has inaugurated a $25 million, 128,000-square-foot Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, significantly bolstering its production capabilities for cell an... -
Forge Biologics Advances AAV Manufacturing with Optimized FUEL Platform and Announces Strategic Expansion into Asia-Pacific Gene Therapy Market
Forge Biologics USA Overview Forge Biologics has announced advancements in its FUEL platform for adeno-associated virus (AAV) manufacturing. This optimization aims to enhance vector yield and consistency during process scale-up through r... -
Drug Discovery News Identifies Critical Bottlenecks in Cell & Gene Therapy Manufacturing: Low Viral Vector Purification Yields and Plasmid DNA Supply Shortages
Drug Discovery News USA Overview Drug Discovery News highlights severe bottlenecks in cell and gene therapy (CGT) manufacturing, specifically in viral vector production. Low downstream purification yields for adeno-associated virus (AAV)... -
Porton Advanced Fortifies End-to-End ATMP CDMO Services with Over 250 Global Clients
Porton Advanced China Overview Porton Advanced is strengthening its end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), serving over 250 global customers. The company offers cell engineering CMC services for autolo...
12